> Something that can model heart rate and blood pressure won't be able to say if a cancer drug will work (or if it will have a toxic side effect) Thanks for ha

> Something that can model heart rate and blood pressure won't be able to say if a cancer drug will work (or if it will have a toxic side effect) Thanks for having a look at Biogears. (edit) Please have a look at: "Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344801/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344801/ https://github.com/katemeeson/repository_to_accompany_paper_2023 https://github.com/katemeeson/repository_to_accompany_paper_... Most successful pre-clinical trials *fail* at predicting phase III success. The ratio is enormous. It's time to put some effort into alternative approaches.